Impressive results of the COMPARE study have recently been published in The Journal of Urology. Prostate cancer patients of all risk groups were willing to trade-off cancer-specific survival for improved quality of life.
Evaluating the Trade-offs Men with Localised Prostate Cancer Make Between the Risks and Benefits of Treatments: The COMPARE Study
Verity Watson at al. J Urol., 2020 Jan
Men with low-intermediate risk prostate cancer were willing to trade:
High-risk prostate cancer patients were willing to trade:
Read more in European Urology:
Fortunately, patients suitable for focal therapy almost certainly do not need to make that trade.